Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review

Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study

(2020) Song Yao et al.   BREAST CANCER RESEARCH AND TREATMENT

Treating osteoporosis to prevent fractures: current concepts and future developments

(2019) Mattias Lorentzon   JOURNAL OF INTERNAL MEDICINE

Reference markers of bone turnover for prediction of fracture: a meta-analysis

(2019) Aixian Tian et al.   Journal of Orthopaedic Surgery and Research

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis

(2019) Mattias Lorentzon et al.   ADVANCES IN THERAPY

Use of bone turnover markers in the management of osteoporosis

(2018) Sumeet Jain et al.   Current Opinion in Endocrinology Diabetes and Obesity

DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?

(2017) Richard Eastell et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Use of bone turnover markers in postmenopausal osteoporosis

(2017) Richard Eastell et al.   Lancet Diabetes & Endocrinology

Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study

(2017) Bo-cheng Liang et al.   Orthopaedic Surgery

Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease

(2016) Matthew B. Greenblatt et al.   CLINICAL CHEMISTRY

Contribution of Lumbar Spine BMD to Fracture Risk in Individuals WithT-Score Discordance

(2015) Dunia Alarkawi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells

(2015) Rinaldo Florencio-Silva et al.   Biomed Research International

Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women

(2014) S. Gonnelli et al.   BONE

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

(2014) Benjamin Z. Leder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study

(2014) M. A. Paggiosi et al.   OSTEOPOROSIS INTERNATIONAL

Biochemical markers of bone turnover – uses and limitations

(2014) Thinn Thinn Hlaing et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study

(2013) C. Roux et al.   BONE

The potential value of monitoring bone turnover markers among women on alendronate

(2011) Katy JL Bell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized Controlled Trial

(2011) Andrew Grey et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

“Twice-a-month” clodronate 200 mg IM: a new dosing regimen and improved therapy adherence in the treatment of postmenopausal osteoporosis

(2010) M. Muratore et al.   ADVANCES IN THERAPY

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

(2010) P. Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

(2010) A. Michael Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis

(2010) J. Iwamoto et al.   OSTEOPOROSIS INTERNATIONAL

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

(2010) S. Vasikaran et al.   OSTEOPOROSIS INTERNATIONAL

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women

(2009) Yoon-Sok Chung et al.   CALCIFIED TISSUE INTERNATIONAL

Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis

(2009) Kathryn M. Ryder et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study

(2009) Douglas C Bauer et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone turnover markers: understanding their value in clinical trials and clinical practice

(2009) R. Civitelli et al.   OSTEOPOROSIS INTERNATIONAL

Role of serum P1NP measurement for monitoring treatment response in osteoporosis

(2008) Michael Samoszuk et al.   Biomarkers in Medicine

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis

(2008) Jun Iwamoto et al.   YONSEI MEDICAL JOURNAL